Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Equity (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Equity for 4 consecutive years, with 0.25% as the latest value for Q4 2025.

  • For Q4 2025, Return on Equity rose 14.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, up 14.0%, while the annual FY2025 figure was 0.24%, 1.0% down from the prior year.
  • Return on Equity was 0.25% for Q4 2025 at Day One Biopharmaceuticals, up from 0.33% in the prior quarter.
  • The five-year high for Return on Equity was 0.2% in Q2 2025, with the low at 0.91% in Q2 2024.
  • Historically, Return on Equity has averaged 0.45% across 4 years, with a median of 0.43% in 2023.
  • The largest annual shift saw Return on Equity crashed -46bps in 2024 before it soared 71bps in 2025.
  • Over 4 years, Return on Equity stood at 0.41% in 2022, then dropped by -25bps to 0.51% in 2023, then increased by 25bps to 0.39% in 2024, then skyrocketed by 36bps to 0.25% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.25% in Q4 2025, 0.33% in Q3 2025, and 0.2% in Q2 2025.